271 related articles for article (PubMed ID: 11356938)
1. In vivo delivery of antisense oligonucleotides in pH-sensitive liposomes inhibits lipopolysaccharide-induced production of tumor necrosis factor-alpha in rats.
Ponnappa BC; Dey I; Tu GC; Zhou F; Aini M; Cao QN; Israel Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):1129-36. PubMed ID: 11356938
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor necrosis factor alpha secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides.
Ponnappa BC; Israel Y; Aini M; Zhou F; Russ R; Cao QN; Hu Y; Rubin R
Biochem Pharmacol; 2005 Feb; 69(4):569-77. PubMed ID: 15670576
[TBL] [Abstract][Full Text] [Related]
3. Reduction of liver tumor necrosis factor-alpha expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis.
Dong L; Zuo L; Xia S; Gao S; Zhang C; Chen J; Zhang J
J Gene Med; 2009 Mar; 11(3):229-39. PubMed ID: 19189285
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor necrosis factor alpha in lipopolysaccharide/ranitidine-induced inflammatory liver injury.
Tukov FF; Luyendyk JP; Ganey PE; Roth RA
Toxicol Sci; 2007 Nov; 100(1):267-80. PubMed ID: 17698507
[TBL] [Abstract][Full Text] [Related]
5. Increases in tumor necrosis factor-alpha in response to thyroid hormone-induced liver oxidative stress in the rat.
Fernandez V; Videla LA; Tapia G; Israel Y
Free Radic Res; 2002 Jul; 36(7):719-25. PubMed ID: 12180121
[TBL] [Abstract][Full Text] [Related]
6. Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha.
Sewell KL; Geary RS; Baker BF; Glover JM; Mant TG; Yu RZ; Tami JA; Dorr FA
J Pharmacol Exp Ther; 2002 Dec; 303(3):1334-43. PubMed ID: 12438559
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor necrosis factor alpha secretion in rat Kupffer cells by siRNA: in vivo efficacy of siRNA-liposomes.
Jing Y; Shishkov A; Ponnappa BC
Biochim Biophys Acta; 2008 Jan; 1780(1):34-40. PubMed ID: 17964727
[TBL] [Abstract][Full Text] [Related]
8. Targeting Kupffer cells with antisense oligonucleotides.
Ponnappa BC; Israel Y
Front Biosci; 2002 May; 7():e223-33. PubMed ID: 11991849
[TBL] [Abstract][Full Text] [Related]
9. Bacterial lipopolysaccharide enhances aflatoxin B1 hepatotoxicity in rats by a mechanism that depends on tumor necrosis factor alpha.
Barton CC; Barton EX; Ganey PE; Kunkel SL; Roth RA
Hepatology; 2001 Jan; 33(1):66-73. PubMed ID: 11124822
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of thalidomide on endotoxin-induced liver injury.
Enomoto N; Takei Y; Hirose M; Kitamura T; Ikejima K; Sato N
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):2S-6S. PubMed ID: 12960498
[TBL] [Abstract][Full Text] [Related]
11. "Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
Fattal E; Couvreur P; Dubernet C
Adv Drug Deliv Rev; 2004 Apr; 56(7):931-46. PubMed ID: 15066753
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor-alpha mediates lipopolysaccharide-induced macrophage inflammatory protein-2 release from alveolar epithelial cells. Autoregulation in host defense.
Xavier AM; Isowa N; Cai L; Dziak E; Opas M; McRitchie DI; Slutsky AS; Keshavjee SH; Liu M
Am J Respir Cell Mol Biol; 1999 Oct; 21(4):510-20. PubMed ID: 10502561
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of endotoxin-induced NO, IL-6, and TNF-alpha production in activated rat hepatic stellate cells: role of p38 MAPK.
Thirunavukkarasu C; Watkins SC; Gandhi CR
Hepatology; 2006 Aug; 44(2):389-98. PubMed ID: 16871588
[TBL] [Abstract][Full Text] [Related]
14. Liposome-encapsulated hemoglobin modulates lipopolysaccharide-induced tumor necrosis factor-alpha production in mice.
Rudolph AS; Cliff R; Kwasiborski V; Neville L; Abdullah F; Rabinovici R
Crit Care Med; 1997 Mar; 25(3):460-8. PubMed ID: 9118663
[TBL] [Abstract][Full Text] [Related]
15. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.
Ulich TR; Guo KZ; Irwin B; Remick DG; Davatelis GN
Am J Pathol; 1990 Nov; 137(5):1173-85. PubMed ID: 2240164
[TBL] [Abstract][Full Text] [Related]
16. Specific suppression of human tumor necrosis factor-alpha synthesis by antisense oligodeoxynucleotides.
Hartmann G; Krug A; Eigler A; Moeller J; Murphy J; Albrecht R; Endres S
Antisense Nucleic Acid Drug Dev; 1996; 6(4):291-9. PubMed ID: 9012865
[TBL] [Abstract][Full Text] [Related]
17. Dicer-substrate siRNA inhibits tumor necrosis factor alpha secretion in Kupffer cells in vitro: in vivo targeting of Kupffer cells by siRNA-liposomes.
Pichu S; Krishnamoorthy S; Zhang B; Jing Y; Shishkov A; Ponnappa BC
Pharmacol Res; 2012 Jan; 65(1):48-55. PubMed ID: 21933712
[TBL] [Abstract][Full Text] [Related]
18. [The effect of transmembrane- and secreted-tumor necrosis factor-alpha on shock liver].
Yin B; Li Z; Yu S; Jiang X; Feng W; Xu Y
Zhonghua Bing Li Xue Za Zhi; 2002 Dec; 31(6):534-7. PubMed ID: 12622907
[TBL] [Abstract][Full Text] [Related]
19. Enhancement by galactosamine of lipopolysaccharide(LPS)-induced tumour necrosis factor production and lethality: its suppression by LPS pretreatment.
Endo Y; Shibazaki M; Yamaguchi K; Kai K; Sugawara S; Takada H; Kikuchi H; Kumagai K
Br J Pharmacol; 1999 Sep; 128(1):5-12. PubMed ID: 10498828
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
